Search research articles
Contact Us
Filters
Showing results (51-60 of 75) with videos related to
Page
of 8
Sort By:
Blood Advances
|
July 24, 2025
Measurable Residual Disease Detection after CAR-T May Predict Response in Patients with Large B-cell Lymphoma
Nira Krasnow, Katie Maurer, Catherine Jiawen Song, et al.
Blood Advances
|
October 31, 2025
A Retrospective Study of Treatment and Outcomes in Synchronous Systemic and Central Nervous System Large B-cell Lymphoma
J Erika Haydu, Robert A Redd, Matthew M Lei, et al.
Journal of Hematology & Oncology
|
February 13, 2025
First-in-human evaluation of memory-like NK cells with an IL-15 super-agonist and CTLA-4 blockade in advanced head and neck cancer
Roman M Shapiro, Michal Sheffer, Matthew A Booker, et al.
Annals of Hematology
|
October 18, 2023
A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma
Reid W Merryman, Robert A Redd, Arnold S Freedman, et al.
Blood
|
April 7, 2019
PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation
Philippe Armand, Yi-Bin Chen, Robert A Redd, et al.
Nature Communications
|
February 5, 2025
Atlas of multilineage stem cell differentiation reveals TMEM88 as a developmental regulator of blood pressure
Sophie Shen, Tessa Werner, Samuel W Lukowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 3, 2018
Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma
Margaretha G M Roemer, Robert A Redd, Fathima Zumla Cader, et al.
Blood Advances
|
November 18, 2022
Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation
Reid W Merryman, Robert A Redd, Eleanor Taranto, et al.
Blood Advances
|
January 10, 2020
PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation
Matthew J Frigault, Philippe Armand, Robert A Redd, et al.
Nature Microbiology
|
October 31, 2024
Post-acute sequelae of SARS-CoV-2 cardiovascular symptoms are associated with trace-level cytokines that affect cardiomyocyte function
Jane E Sinclair, Courtney Vedelago, Feargal J Ryan, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 75) with videos related to
Sort By:
Page
of 8
Blood Advances
|
July 24, 2025
Measurable Residual Disease Detection after CAR-T May Predict Response in Patients with Large B-cell Lymphoma
Nira Krasnow, Katie Maurer, Catherine Jiawen Song, et al.
Blood Advances
|
October 31, 2025
A Retrospective Study of Treatment and Outcomes in Synchronous Systemic and Central Nervous System Large B-cell Lymphoma
J Erika Haydu, Robert A Redd, Matthew M Lei, et al.
Journal of Hematology & Oncology
|
February 13, 2025
First-in-human evaluation of memory-like NK cells with an IL-15 super-agonist and CTLA-4 blockade in advanced head and neck cancer
Roman M Shapiro, Michal Sheffer, Matthew A Booker, et al.
Annals of Hematology
|
October 18, 2023
A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma
Reid W Merryman, Robert A Redd, Arnold S Freedman, et al.
Blood
|
April 7, 2019
PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation
Philippe Armand, Yi-Bin Chen, Robert A Redd, et al.
Nature Communications
|
February 5, 2025
Atlas of multilineage stem cell differentiation reveals TMEM88 as a developmental regulator of blood pressure
Sophie Shen, Tessa Werner, Samuel W Lukowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 3, 2018
Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma
Margaretha G M Roemer, Robert A Redd, Fathima Zumla Cader, et al.
Blood Advances
|
November 18, 2022
Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation
Reid W Merryman, Robert A Redd, Eleanor Taranto, et al.
Blood Advances
|
January 10, 2020
PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation
Matthew J Frigault, Philippe Armand, Robert A Redd, et al.
Nature Microbiology
|
October 31, 2024
Post-acute sequelae of SARS-CoV-2 cardiovascular symptoms are associated with trace-level cytokines that affect cardiomyocyte function
Jane E Sinclair, Courtney Vedelago, Feargal J Ryan, et al.
Page
of 8